生命科学资讯

FDA’s Vinay Prasad to depart agency at the end of April

Life Sciences Tools & Services Stocks Q4 In Review: 10x Genomics (NASDAQ:TXG) Vs Peers - Yahoo Finance Australia

Vinay Prasad, controversial FDA leader, to again depart agency

President Donald Trump to visit Cincinnati to tout push for lower drug prices - WLWT

Vinay Prasad to exit FDA again, following latest round of controversy

Agilent Technologies announces planned retirement of principal accounting officer - Investing.com

Kevin Hern acquires Waters Corporation stock through Hern Family Revocable Trust - Investing.com

Lonza shakes off capsule business in $3B deal with Lone Star - Fierce Pharma

FDA to end 9-month advisory committee drought with April review of AstraZeneca’s oral SERD, Truqap

Lonza sells capsule and health ingredients unit for $2.2B

Lonza sells capsule and health ingredients unit to UK's Lone Star for $2.2B - Endpoints News

Genomics, multiomics, and spatial biology at AGBT 2026 - C&EN

Agilent Technologies, Inc. (A) Price Target Cut to $155 at Baird - Finviz

Lonza Seals CHF 2.3 Billion CHI Sale to Complete Shift to Pure-Play CDMO - TipRanks

Lonza to sell capsule and health ingredients business to Lone Star for $3.0 billion - Reuters

Servier to build cancer drug pipeline with $2.5B purchase of Day One

Roche, Zealand shares fall on ‘undifferentiated’ obesity drug results

Lonza Completes its Transformation to a Pure-Play CDMO with Agreement to Divest Capsules & Health Ingredients - TradingView

Other news to note for March 6, 2026

Regulatory actions for March 6, 2026